Barely Significant
← all excerpts

Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis.

Transl Vis Sci Technol · 2023 · PMC10064916 · PMID 36976157

2
hedged sentences
closest p
boldest claim

The sentences

a clear trendno p-value reported
However, when compared to untreated fellow eyes of the same animal there was a clear trend toward improved inflammation scores in the eyes that received acazicolcept injection.

also in 8,934 other papers

showed a trendno p-value reported
Treatment with acazicolcept or corticosteroids showed a trend toward decreasing concentrations of all cytokines measured, but no changes were statistically significant after controlling for multiple comparisons.

also in 23,610 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.